Antonella Antignani

1.3k total citations · 1 hit paper
34 papers, 1.0k citations indexed

About

Antonella Antignani is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Antonella Antignani has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Molecular Biology and 9 papers in Biotechnology. Recurrent topics in Antonella Antignani's work include Toxin Mechanisms and Immunotoxins (19 papers), Cell death mechanisms and regulation (10 papers) and Transgenic Plants and Applications (8 papers). Antonella Antignani is often cited by papers focused on Toxin Mechanisms and Immunotoxins (19 papers), Cell death mechanisms and regulation (10 papers) and Transgenic Plants and Applications (8 papers). Antonella Antignani collaborates with scholars based in United States, Italy and United Kingdom. Antonella Antignani's co-authors include Richard J. Youle, David Fitzgerald, Maria Teresa Bilotta, Giuseppe D’Alessio, Aniello Russo, David J. FitzGerald, Nathan C. Simon, Francesca M. Marassi, Yuanyuan Yao and L. Miya Fujimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Antonella Antignani

33 papers receiving 998 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Managing the TME to improve the efficacy of cancer therapy

2022 172 citations Maria Teresa Bilotta, Antonella Antignani et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Antonella Antignani

Since Specialization

Citations

This map shows the geographic impact of Antonella Antignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Antignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Antignani more than expected).

Fields of papers citing papers by Antonella Antignani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Antignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Antignani. The network helps show where Antonella Antignani may publish in the future.

Co-authorship network of co-authors of Antonella Antignani

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Antignani. A scholar is included among the top collaborators of Antonella Antignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Antignani. Antonella Antignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Birinapant selectively enhances immunotoxin‐mediated killing of cancer cells conditional on the IAP protein levels within target cells 2023 ·The FASEB Journal ·Antonella Antignani, Maria Teresa Bilotta, Jacob S. Roth, Daniel J. Urban, Min Shen, Matthew D. Hall, David Fitzgerald	0
2	Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity 2022 ·Biomedicine & Pharmacotherapy ·Eric Ho, Rong Qiu, (unknown), Maria Teresa Bilotta, David FitzGerald, Antonella Antignani	10
3	Managing the TME to improve the efficacy of cancer therapy breakdown → 2022 ·Frontiers in Immunology ·Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald	172
4	Characterization of monoclonal antibodies generated to the 287–302 amino acid loop of the human epidermal growth factor receptor 2019 ·PubMed ·Eric Ho, Antonella Antignani, (unknown), David Fitzgerald	4
5	Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins 2017 ·Oncogene ·Antonella Antignani, David Segal, Nathan C. Simon, Robert J. Kreitman, David C.S. Huang, David J. FitzGerald	11
6	Ranking Differential Drug Activities from Dose-Response Synthetic Lethality Screens 2016 ·SLAS DISCOVERY ·Rajarshi Guha, Lesley A. Mathews Griner, Jonathan M. Keller, Xiaohu Zhang, David Fitzgerald, Antonella Antignani, Ira Pastan, Craig J. Thomas, Marc Ferrer	4
7	Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins 2016 ·PLoS ONE ·Antonella Antignani, Lesley A. Mathews Griner, Rajarshi Guha, Nathan C. Simon, (unknown), Jonathan M. Keller, (unknown), (unknown), Ira Pastan, Marc Ferrer, David Fitzgerald, Craig J. Thomas	8
8	Conformation of BCL-XL upon Membrane Integration 2015 ·Journal of Molecular Biology ·Yuanyuan Yao, L. Miya Fujimoto, (unknown), Andrey A. Bobkov, Antonella Antignani, Richard J. Youle, Francesca M. Marassi	53
9	ABT-737 Promotes the Dislocation of ER Luminal Proteins to the Cytosol, Including Pseudomonas Exotoxin 2014 ·Molecular Cancer Therapeutics ·Antonella Antignani, (unknown), David Fitzgerald	16
10	Combining the Antimesothelin Immunotoxin SS1P With the BH3-mimetic ABT-737 Induces Cell Death in SS1P-resistant Pancreatic Cancer Cells 2013 ·Journal of Immunotherapy ·Kevin Hollevoet, Antonella Antignani, David J. FitzGerald, Ira Pastan	15
11	Proteolytic Cleavage of a C-terminal Prosequence, Leading to Autoprocessing at the N Terminus, Activates Leucine Aminopeptidase from Pseudomonas aeruginosa 2009 ·Journal of Biological Chemistry ·(unknown), Jennifer C. Rea, (unknown), Ralf Hertle, (unknown), Antonella Antignani, Diana V. Pastrana, David J. FitzGerald	19
12	Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin 2009 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), (unknown), Antonella Antignani, (unknown), Jingli Zhang, Raffit Hassan, David Fitzgerald	18
13	Bax Activates Endophilin B1 Oligomerization and Lipid Membrane Vesiculation 2009 ·Journal of Biological Chemistry ·Tatiana K. Rostovtseva, Hacène Boukari, Antonella Antignani, (unknown), Soojay Banerjee, Albert Neutzner, Richard J. Youle	37
14	Endosome fusion induced by diphtheria toxin translocation domain 2008 ·Proceedings of the National Academy of Sciences ·Antonella Antignani, Richard J. Youle	12
15	p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosis 2008 ·Cell Death and Differentiation ·Mitzi M. Donaldson, Antonella Antignani, Joshua D. Milner, Nannan Zhu, (unknown), (unknown), (unknown), Stephen H. Jackson	10
16	The Cytokine, Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Can Deliver Bcl-XL as an Extracellular Fusion Protein to Protect Cells from Apoptosis and Retain Differentiation Induction 2007 ·Journal of Biological Chemistry ·Antonella Antignani, Richard J. Youle	8
17	How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? 2006 ·Current Opinion in Cell Biology ·Antonella Antignani, Richard J. Youle	227
18	Engineering the Refolding Pathway and the Quaternary Structure of Seminal Ribonuclease by Newly Introduced Disulfide Bridges 2002 ·Journal of Biological Chemistry ·Aniello Russo, Antonella Antignani, Concetta Giancola, Giuseppe D’Alessio	1
19	The Antarctic Psychrobacter sp. TAD1 has two cold-active glutamate dehydrogenases with different cofactor specificities. Characterisation of the NAD+-dependent enzyme 2002 ·Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology ·Laura Camardella, (unknown), Antonella Antignani, Maria Antonietta Ciardiello, Guido di Prisco, (unknown), (unknown), (unknown), Nicholas J. Russell	13
20	NADP⁺‐dependent glutamate dehydrogenase in the Antarctic psychrotolerant bacterium Psychrobacter sp. TAD1 2000 ·European Journal of Biochemistry ·(unknown), Valérie Wilquet, Maria Antonietta Ciardiello, Vito Carratore, Antonella Antignani, Laura Camardella, Nicolas Glansdorff, Guido di Prisco	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact